Yan Li successfully defends his dissertation

Congratulations to Yan Li for the successful defense of his thesis Epidemiology and Safety of Skeletal Muscle Relaxants and Concomitant Opioid or Psychotropic Medication Use. Immediately after defending his dissertation, Yan became an ORISE fellow in the Division of Pulmonary, Allergy and Rheumatology Products (DPARP) at the Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration (FDA). In this role, he will lead a new pilot program to explore the potential of using real-world data/evidence to support regulatory decisions about product effectiveness.